Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Therapy on Choroidal Thickness in Neovascular Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography
Name
Fujimoto_Effect of intravitreous.pdf
Size
1.22 MB
Format
Adobe PDF
Checksum (MD5)
33b0b4eabe98012071243629464b5602
Author(s)
Branchini, Lauren
Regatieri, Caio
Adhi, Mehreen
Flores-Moreno, Ignacio
Manjunath, Varsha
Fujimoto, James G.
Duker, Jay S.
Date Issued
March 2013
Journal
JAMA Ophthalmology
Publisher
American Medical Association
Citation
Branchini, Lauren, Caio Regatieri, Mehreen Adhi, Ignacio Flores-Moreno, Varsha Manjunath, James G. Fujimoto, and Jay S. Duker. “Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Therapy on Choroidal Thickness in Neovascular Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography.” JAMA Ophthalmol 131, no. 5 (May 1, 2013): 693.
Version
Author's final manuscript
Abstract
A critical method of monitoring patients with neovascular age-related macular degeneration (AMD) being treated with anti–vascular endothelial growth factor (anti-VEGF) is optical coherence tomography (OCT), which uses low-coherence interferometry of light to examine the retina in vivo on a micrometer scale.
MIT Department
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Massachusetts Institute of Technology. Research Laboratory of Electronics
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1001/jamaophthalmol.2013.692
